Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Zolpidem for the Treatment of Neurologic Disorders
JAMA Neurol 74:1130-1139, Bomalaski, M.N.,et al, 2017
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Tourettes Syndrome
BMJ 347:f4964, Cavanna, A.E. & Seri, S., 2013
Making Every Word Count for Nonresponsive Patients
JAMA Neurol 70:1235-1241, Naci, L. & Owen, A.M., 2013
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007
Aneurysmal Subarachnoid Hemorrhage
NEJM 354:387-396, Suarez,J.I.,et al, 2006
Chronic Daily Headache With Analgesic Overuse
Neurol 62:1338-1342, Colas,R.,et al, 2004
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
An Aggressive Approach to Massive Middle Cerebral Artery Infarction
Arch Neurol 50:1293-1297, Kalia,K.K.&Yonas,H., 1993
Acquired Neuropathologic Lesions Associated with the Hypoplastic Left Heart Syndrome
Pediatrics 85:991-1000, Glauser,T.A.,et al, 1990